Related Experiment Video
Updated: Jul 19, 2025

Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
Swedish obstetric thromboprophylaxis guideline: background and update
Pelle G Lindqvist1,2, Eli Westerlund3, Margareta Hellgren4,5
1Department of Clinical Sciences and Education, Karolinska Institutet, Södersjukhuset, Sweden.
Swedish obstetricians use a validated risk algorithm to identify pregnant women needing venous thromboembolism (VTE) prophylaxis. This guideline minimizes under- and overtreatment, ensuring appropriate care for high-risk pregnancies.
Area of Science:
- Obstetrics and Gynecology
- Hematology
- Public Health
Background:
- Venous thromboembolism (VTE) risk assessment and prophylaxis are standard in pregnancy.
- Swedish obstetricians have utilized a weighted-risk algorithm for VTE risk estimation for two decades.
Purpose of the Study:
- To present the latest update of the Swedish VTE risk algorithm for obstetric patients.
- To detail the algorithm's basis, application in assessing moderate-to-high risk, and efficacy.
- To describe associated lifestyle advice for pregnant individuals.
Main Methods:
- A weighted-risk algorithm based on factors conferring a fivefold or greater VTE risk.
- Risk assessment defines patients requiring thromboprophylaxis based on absolute risk thresholds.
- Efficacy data and patient lifestyle advice are presented.
Main Results:
- The algorithm identifies pregnant women at moderate-to-high risk for VTE.
- It guides patient selection, timing, duration, and dosage of thromboprophylaxis.
- The guideline is user-friendly and aids in minimizing treatment disparities.
Conclusions:
- The updated Swedish guideline provides an effective and practical approach to obstetric VTE risk management.
- It facilitates accurate identification of high-risk individuals, optimizing thromboprophylaxis.
- This strategy helps reduce the risks of both under- and overtreatment in pregnant populations.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Pulmonary Embolism III: Nursing Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

